Lauren Pinter-Brown, MD, UCLA Jonsson Comprehensive Cancer Center, has been on the UCLA staff since 1990 and the Director of their Lymphoma Program since 2005. She has an extensive background and focus in T-cell lymphomas and concentrates on optimizing treatment for patients diagnosed with lymphomas. She is the principal investigator for clinical research protocols for patients with Hodgkin's disease, B-cell lymphomas, CD30+ Anaplastic large-cell lymphoma and T-cell lymphomas.
Dr. Pinter-Brown has been a member of the CLF’s Medical Advisory Board since 2000, and has provided editorial and speaking services. She has been an editorial contributor to the CLF’s Forum and has served as a reviewer for many medical publications, including The American Journal of Hematology, Journal of Clinical Dermatology and Journal of Clinical Oncology. She also lectures extensively on leukemia, T-cell lymphoma and cutaneous T-cell lymphoma.
Dr. Pinter-Brown also serves on the Board of Directors of the United States Cutaneous Lymphoma Consortium and is a member of the American Society of Clinical Oncology, American Society of Hematology and the International Society for Cutaneous Lymphoma, among others. She has held various positions with patient advocacy organizations, including the Lymphoma Research Foundation and Ted Mann Family Resource Center.